COPD Trial, Recruiting (NCT06732869)

COPD Trial, Recruiting NCT06732869 Sponsor: Instituto Politécnico de Leiria Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06732869 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 40 years old
People who have been diagnosed with COPD (a lung condition affecting breathing) according to standard medical guidelines, and whose condition is currently stable, meaning no flare-ups in the past month
People who are already enrolled in a pulmonary rehabilitation program (a structured program to help manage lung conditions)
People who own a smartphone with internet access
People who are able to understand the study information and agree to take part

Who may not be able to join:

People who are currently taking part in another program aimed at changing health behaviours
People who have a health condition that would make it unsafe to take part in a physical activity program, such as severe joint or muscle problems, severe nervous system disorders, or an unstable heart condition
People who have a different primary lung or breathing condition other than COPD
People who have had a cancer diagnosis or received cancer treatment within the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sofia Flora, PT, MSc, Center for Innovative Care and Health Technology, Polytechnic of Leiria

Phone: +351 917257840

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06732869

Sponsor: Instituto Politécnico de Leiria

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: +351 917257840

More information: https://clinicaltrials.gov/study/NCT06732869

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 40 years old
People who have been diagnosed with COPD (a lung condition affecting breathing) according to standard medical guidelines, and whose condition is currently stable, meaning no flare-ups in the past month
People who are already enrolled in a pulmonary rehabilitation program (a structured program to help manage lung conditions)
People who own a smartphone with internet access
People who are able to understand the study information and agree to take part

Who may not be able to join:

People who are currently taking part in another program aimed at changing health behaviours
People who have a health condition that would make it unsafe to take part in a physical activity program, such as severe joint or muscle problems, severe nervous system disorders, or an unstable heart condition
People who have a different primary lung or breathing condition other than COPD
People who have had a cancer diagnosis or received cancer treatment within the past year

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Instituto Politécnico de Leiria

Registry

ClinicalTrials.gov

Start date

2 December 2024

Est. completion

1 June 2025

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

Accelerometry (number of daily steps)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov